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In Brief
Belin et al. used comparative proteomics
approaches and revealed a signaling
network of injury responses in
axotomized retinal ganglion cells and also
demonstrated c-myc as a critical
regulator of neuronal survival and axon
regeneration.
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Neurons differ in their responses to injury, but the
underlying mechanisms remain poorly understood.
Using quantitative proteomics, we characterized
the injury-triggered response from purified intact
and axotomized retinal ganglion cells (RGCs). Sub-
sequent informatics analyses revealed a network of
injury-response signaling hubs. In addition to con-
firming known players, such asmTOR, this also iden-
tified new candidates, such as c-myc, NFkB, and
Huntingtin. Similar to mTOR, c-myc has been impli-
cated as a key regulator of anabolic metabolism
and is downregulated by axotomy. Forced expres-
sion of c-myc in RGCs, either before or after injury,
promotes dramatic RGC survival and axon regenera-
tion after optic nerve injury. Finally, in contrast to
RGCs, neither c-myc nor mTOR was downregulated
in injured peripheral sensory neurons. Our studies
suggest that c-myc and other injury-responsive
pathways are critical to the intrinsic regenerative
mechanisms and might represent a novel target for
developing neural repair strategies in adults.
INTRODUCTION
In the adult mammalian CNS, axotomy often triggers neuronal
death, and spontaneous axon regeneration rarely occurs. An
implicated mechanism is the diminished intrinsic regenerative
ability of mature CNS neurons (Fawcett, 2006; Goldberg et al.,
2002b; Moore et al., 2009; Park et al., 2008). Based on the differ-
ences in axon growth between immature and mature neurons, it
has been proposed that the neuronal intrinsic growth ability is
lost over the course of development. Therefore, much effort
has beenmade to seekmolecular pathways that are differentially
expressed during development and in the adult, resulting in
the identification of several axon regeneration regulators. For1000 Neuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc.example, in many types of neurons, cAMP levels appear to be
higher in the immature neurons, but decline in the mature neu-
rons (Cai et al., 2001; Filbin, 2003). By analyzing the axon growth
of retinal ganglion cells (RGCs) from different developmental
stages, Goldberg et al. showed a development-dependent
decline of axon growth rate, with a dramatic decrease in post-
natal RGCs (Goldberg et al., 2002a). Further, recent studies
implicated transcription factors from the Kru¨ppel-like family
of transcription factors (KLFs) as critical regulators of develop-
ment-dependent axon growth ability in RGCs (Moore et al.,
2009). Interestingly, while KLF7 is downregulated, other mem-
bers, such as KLF4, are upregulated during development.
Importantly, manipulations of these factors could promote the
regrowth of injured optic nerve axons and corticospinal tract
axons in the adult (Blackmore et al., 2012).
However, ample evidence indicates that even in the adult
CNS, many uninjured neurons possess considerable capacity
for structural plasticity and collateral sprouting (Holtmaat and
Svoboda, 2009; Raineteau and Schwab, 2001). For example,
upon incomplete spinal cord injury in the adult, spared axons
have been repetitively shown to elaborate spontaneous sprout-
ing responses (Bareyre et al., 2004; Rosenzweig et al., 2010).
Furthermore, such sprouting responses could be further
enhanced by rehabilitation training (Harel et al., 2013; van den
Brand et al., 2012). This is in contrast to no or limited regrowth
from injured axons in the adult CNS (Bradke et al., 2012; Gold-
berg et al., 2002b; Moore et al., 2009; Park et al., 2008; Rossi
et al., 2007). Therefore, it is possible that in addition to develop-
ment-dependent processes, axonal injury-triggered stress re-
sponses might contribute to the impaired intrinsic regenerative
ability of mature neurons.
While many previous studies documented gene expression
changes in different types of injured neurons (Costigan et al.,
2002; Michaelevski et al., 2010; Saul et al., 2010; Tanabe et al.,
2003; Fischer et al., 2004), pinpointing key molecular pathways
that orchestrate neuronal survival and axon regeneration re-
mains a major challenge. One possible reason is that axotomy
may impinge on both gene transcription as well as protein trans-
lation and degradation. Thus, analyzing the transcriptome may
not reflect the full scope of injury-induced changes in neurons.
As protein abundance is the final readout of gene expression,
translation, and degradation, analyzing injury-induced changes
in protein abundance may provide a direct assessment of
neuronal injury responses. Although proteomic methods have
been used extensively for the analyses of cultured cells and
whole tissues (Chen andSpringer, 2009; Kimet al., 2014;Magha-
rious et al., 2011; Wilhelm et al., 2014), very few studies have uti-
lized procedures to analyze a specific type of primary neurons
purified directly from live tissue. In this study, we performed a
quantitative proteomics experiment to profile changes in protein
abundance in RGCs induced by optic nerve injury relative to an
uninjured control. Subsequent informatics analyses identified a
set of injury-response pathways that have an impact on the
intrinsic growth ability and regenerative responses after injury.
RESULTS
Quantitative Proteomic Analysis of Intact and Injured
RGCs
As an optic nerve injury transects the axons from all RGCs in the
retina, it is an ideal model for isolating homogenously injured
neurons and analyzing their injury responses. This is further facil-
itated by the availability of the transgenic mouse line YFP-17
(Sun et al., 2011), in which the yellow fluorescent protein (YFP)
is predominantly expressed in the RGCs and in a few amacrine
cells (Figure S1A). Using these YFP-17 mice, we performed an
optic nerve injury on one eye of these animals and left the other
eye uninjured as control. At 3 days post-injury before extensive
apoptotic death has occurred, axotomized and intact retinas
were dissected out, and dissociated cells were subjected to fluo-
rescence-activated cell sorting (FACS) purification.
FACS gating parameters were optimized to select cells based
on size, viability (DAPI-negative cells), and YFP+ signal (Fig-
ure 1A) and resulted in the isolation of 99% viable YFP+ cells
(Figure S1B). In this experiment, the isolation of a subset of neu-
rons, i.e., predominantly RGCs, results in the specific analysis of
the injury response to the optic nerve. We collected three biolog-
ical replicate samples, each of which consists of a pool of injured
or control RGCs (15 retinas per pooled replicate corresponding
to 1.5 3 106 cells). Samples were lysed, and total protein con-
centrations were measured for the lysates using BCA. Equal
amounts of protein from individual samples were digested using
trypsin, and the resultant peptides were labeled with one of the
six tandem mass tags (TMTs). These samples were then mixed
and fractionated using isoelectric focusing. Less than 10 mg
from each fraction was subjected to LC-MS/MS analysis using
the standardmethods and Pulsed-Q dissociation (PQD) to quan-
tify the TMT reporter ions on an Orbitrap Classic instrument
(Griffin et al., 2007; Thompson et al., 2003). The resulting spectra
were searched withMASCOT (v2.1) against an annotatedmouse
protein database (IPI 3.68) to identify spectral matches to anno-
tated peptides. These matched spectra (peptide spectral
matches, PSMs) corresponded to 7,514 unique peptides and
were grouped into 1,409 proteins using a 1% false-discovery
rate (FDR) cutoff and aminimumof two peptides per protein (Fig-
ure 1C; Table S1). Proteins were identified from a range of sub-
cellular compartments, such as the cytoplasm (60%), nucleus
(18%), and plasma membrane (14%), and functional classes,such as kinases/phosphatases, transcriptional regulators, or
ion channels. This result indicates that a broad functional depth
of the proteome was measured (Figure S2; Table S2).
Protein abundance was analyzed in a pairwise fashion within
biological samples of RGCs with injured optic nerves and their
control RGCs from uninjured optic nerves from the same animals
and plotted as the ratio of expression in the injured sample
divided by expression in the control (log2 scale), revealing that
the majority of identified proteins showed similar abundance
values before and after injury (Figure 1D). Interestingly, 62 pro-
teins were significantly increased or decreased, respectively, in
the injured RGCs compared to the uninjured control (Figure 1D;
Table S2).
Functional Annotation of Injury-Altered Proteins
Next, we used Ingenuity Pathway Analysis (IPA) (Park et al.,
2013) to assesswhich cellular functionsmight be related to these
62 altered proteins that are affected in the injury response. As
shown in Figure 2A and Table S3, most downregulated proteins
appear to be associated with cellular functions such as formation
of cellular protrusions, organization of cytoskeleton, and micro-
tubule dynamics. Since these processes represent critical steps
of axon regeneration, these changes might reflect the reduced
intrinsic regenerative ability of injured RGCs.
Putative Key Regulators of Injury Responses Revealed
by Informatics Analysis
We reasoned that such protein abundance alterations might
reflect the outcomes of injury response-signaling events. There-
fore, we subjected these 62 proteins to an IPA-based network
analysis (Staab et al., 2007) in order to findmajor signaling events
occurring in axotomized RGCs. This analysis revealed nine
signaling networks (Figure S2C; Table S4) and relevant signaling
hubs (Figure S2C). The top 12 signaling hubs are listed in Figures
2B and 2C.
Strikingly, this list includes several known regulators of
neuronal survival and axon regeneration, such as TP53, Ca2+
(Ghosh-Roy et al., 2010; Chierzi et al., 2005; Sung et al., 2001;
Bradke et al., 2012), MAPK (Chen et al., 2011; Hammarlund
et al., 2009; Watkins et al., 2013), JAK (Smith et al., 2009; Sun
et al., 2011), and the components of mTOR pathway, such as
Rictor, Raptor, and mTOR (Dupraz et al., 2013; Liu et al., 2010;
Near et al., 1992; Park et al., 2008; Toth et al., 2006; Zhu et al.,
2010), validating the use of this approach in analyzing neuronal
injury responses. Interestingly, this list also includes several
other molecules, such as c-myc, Huntingtin (HTT), and NFkB
(Figures 2B and 2C), which might represent new candidates for
critical regulators of the neuronal injury response.
c-myc Expression Is Downregulated in RGCs in
Response to Injury
Our further analysis has been focused on c-myc, which was one
of the most connective nodes of the regulator network (Figures
2B and 2C; Table S4). c-myc was not among the 1,409 proteins
identified by proteomics analysis (Tables S1 and S2), possibly
due to its low protein abundance in adult RGCs. However,
among 62 injury-altered proteins identified from our proteomics
analysis, ten proteins (highlighted in red in Table S4) haveNeuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc. 1001
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Figure 1. Proteomics Analysis of the RGCs before and 3 Days after Optic Nerve Crush
(A) Representative FACS plots illustrating the steps of RGCs purification. Dissociated retinal cells were gated based on size and surface characteristics (forward
scatter, FSC-A, x axis; side scatter, SSC-A, y axis; first graph from left). DAPI-positive neurons, staining dead cells depicted in blue, are excluded by sorting
(second graph from left). Retinal cells without YFPwere used as controls to set up the threshold for YFP+ cells (third graph). The last graph shows the population of
YFP+ RGCs that were selected.
(B) A schematic of themultiplexed quantitative proteomics workflow. Retinas from uninjured YFP17mice (notedWT, wild-type) and from YFP17mice 3 days post
optic nerve crush (WTc) were collected (i). After dissociation, YFP+ neurons were purified by FACS (ii). Three independent biological replicate samples were
collected for each condition (each sample from at least 15 retinas) and subjected to cell lysis (iii) and tryptic digestion (iv). Samples were then labeled with specific
mass-coded TMT tags (illustrated with different colors) prior to mixing (v), OFFgel fractionation (vi), LC-MS/MS, and informatics analyses to identify and quantify
peptide spectrum matches (PSMs) (vii–x).
(C) Table of the numbers of PSMs, unique peptides, and proteins identified from our analysis.
(D) The plot showing the quantitative distribution of the 1,409 identified proteins according to their log2 expression ratio (injured/control).
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Figure 2. Functional Annotation and Network Analysis of Injury-Altered Proteins in RGCs
(A) Protein ontology categories enriched in the proteins affected by injury. IPA analysis indicates upregulation (in orange), downregulation (in blue,) or non-
predictable (in white) function variation after injury for each cluster. The size of each square is proportional to the number of altered proteins in this functional
category.
(B) Major hubs from the merged network analysis of injury-altered proteins. Factors and/or pathways of interest are added in this interaction web based on their
targets.
(C) Table of major regulators ranked based on their numbers of total interactions (nodes) in the interaction web.functional interactions with c-myc in the network. Importantly,
similar to mTOR (Howell et al., 2013; Laplante and Sabatini,
2012; Shaw and Cantley, 2006), c-myc has been implicated asa master control gene of cellular metabolism (Dang, 2013), posi-
tioning it as an excellent candidate to improve RGCs survival and
axon regeneration.Neuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc. 1003
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Figure 3. c-myc Expression Promotes Neuronal Survival and Axon Regeneration after Optic Nerve Injury
(A) Timeline of the experimental procedures.
(B) c-mycmRNA levels in intact and injured RGCs detected by real-time qPCR. mRNA samples were extracted from purified RGCs isolated from YFP+ retina at
3 days post injury or from intact control retinas. Results are normalized to GAPDH. **p < 0.01, t test. Error bars indicate SEM.
(C) Representative images of retinal sections stained with anti-c-myc (in red), anti-Tuj1 (in green) antibodies, and DAPI (in blue). Scale bar, 20 mm.
(D) Scheme of experimental procedures to assess axonal regeneration.
(legend continued on next page)
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To verify the involvement of c-myc in the injury response, we
examined the expression level of c-myc before and after injury.
Using real-time qPCR analysis of mRNA purified from samples
subjected to identical treatments as in the proteomics experi-
ments (Figure 1), we observed that the expression of c-myc
mRNA is decreased by 70% after injury (Figures 3A and 3B).
This injury-induced c-myc downregulation was also verified by
immunohistochemistry with anti-c-myc antibodies on retinal
sections from intact and injured mice (Figure 3C). These results
together verified the injury-induced c-myc downregulation in
injured RGCs.
Overexpression of c-myc in RGCs Promotes Axon
Regeneration In Vivo
We next assessed the effects of c-myc overexpression on
neuronal responses by two different approaches. First, as we
demonstrated previously, injection of adeno-associated virus
serotype 2 (AAV2) vectors into the vitreous body results in highly
selective and efficient transduction to RGCs (Park et al., 2008;
Sun et al., 2011), thus we injected AAV2 expressing c-myc or a
control placenta alkaline phosphatase (PLAP) into the vitreous
body of adult mice. These mice were then subjected to a stan-
dard optic nerve injury procedure, followed by a cholera toxin
B subunit (CTB) injection to analyze neuronal survival and axon
regeneration (Park et al., 2008). At 2 weeks post-injury, we
observed that 49% of RGCs survived in c-myc-overexpressing
mice, whereas only 25% survived in the mice injected with
AAV2-PLAP (Figures S3A and S3B). Importantly, a significant
axonal growth increase was observed in the optic nerves from
c-myc-overexpressing mice (Figures S3C and S3D), suggesting
that c-myc overexpression could promote both neuronal survival
and axon regeneration after injury.
As an independent approach to assess the effect of c-myc
overexpression, we used an inducible c-myc transgenic mouse
line, ROSAMER mice (Ja¨ger et al., 2004). In these mice, a
cassette with the gene encoding a tamoxifen-inducible c-my-
cERT fusion protein (mycERT) downstream of a lox-stop-lox
sequence was inserted in the ubiquitously active ROSA26 locus.
Therefore, mycERT transcription is Cre dependent, and the ac-
tivity of the fusion protein is tamoxifen inducible. We then tested
the effect of a transient activation of c-myc prior to injury. After
the intravitreal injection of AAV2-Cre or AAV2-PLAP, and subse-
quent tamoxifen induction, these mice were subjected to optic
nerve injury (Figure 3D). As shown in Figures 3E–3G, both robust
neuronal survival and axon regeneration were observed in the
mice injected with AAV2-Cre, but not with control AAV2-PLAP.
The extent of the regenerative response was comparable to
that observed in PTEN-deleted mice (Park et al., 2008). These
phenotypes are more robust than what was observed after
AAV2-c-myc expression (Figure S3), possibly due to a more effi-
cient expression of c-myc in these transgenic mice. We also(E) Representative confocal images of CTB-labeled optic nerve sections from Ro
(n = 7). Red stars indicate the crush site. Scale bar, 100 mm.
(F) Quantification of the numbers of regenerative axons counted at different distan
indicate SEM.
(G) Quantification of survived RGCs as detected by anti-Tuj1 immunostaining in wh
c-myc mice with injection of AAV2-PLAP (n = 5) or AAV2-Cre (n = 5). ***p < 0.001monitored the mTOR activity in RGCs under these treatments,
3 days after injury, by immunohistochemistry using antibodies
against phosphorylated-ribosome protein S6 (P-S6), an estab-
lished indicator of the mTOR activity (Guertin and Sabatini,
2007). As shown in Figure S4, RGCs with c-myc overexpression
still exhibited significant injury-induced mTOR downregulation,
although the extent of downregulation is less than that observed
for the controls. These data further support the notion that c-myc
overexpression is able to promote RGC axon regeneration after
optic nerve injury.Delayed c-myc Overexpression Still Promotes Optic
Nerve Regeneration
To mimic clinically relevant settings, we assessed the effects of
expressing c-myc after a delayed post-injury period. We thus
administered tamoxifen to ROSAMER mice starting from
1 day after optic nerve injury (Figure 4A). At 2 weeks post-injury,
we observed that approximately 55% of RGCs survived, in
comparison with 25% in controls (Figures 4D and 4E). In addi-
tion, significant numbers of regenerating axons were observed
in the animals with delayed c-myc expression with many regen-
erating axons growing beyond the injury site and extending
1.5 mm from the crush site (Figures 4B and 4C). As the
apoptotic pathways might be activated at these axotomized
RGCs (Figure 2), our results suggest that c-myc can rescue
these injured neurons from apoptotic death and promote their
axon regeneration.c-myc Is Essential for Regenerative Phenotype of PTEN
Deletion
The experiments above implicated injury-induced c-myc down-
regulation as an important mechanism reducing the intrinsic
regenerative ability of adult RGCs. We then investigated whether
c-myc is required for axon regeneration in adult RGCs induced
by other manipulations. Since PTEN inhibition was previously
shown to activate mTOR and promote neuronal survival and
axon regeneration (Liu et al., 2010; Park et al., 2008; de Lima
et al., 2012), we thus examined whether a genetic knockout of
c-myc might affect the axon regeneration induced by shRNA-
mediated PTEN silencing (Zukor et al., 2013). We co-injected
AAV2-ShPTEN with AAV2-Cre or AAV2-PLAP into the vitreal
body of the c-mycf/f mice and performed optic nerve injury after
4 weeks. As expected, PTEN silencing by shRNA resulted in sig-
nificant axon regeneration as analyzed at 2 weeks post-injury
(Figures S5A and S5B). The knockout of c-myc significantly
reduced the numbers of regenerating axons (Figures S5A and
S5B), but did not affect neuronal survival (Figures S5C and
S5D) or the mTOR activity (Figure S5E). However, some residual
regenerating axons were still observed after c-myc deletion (Fig-
ures S5A and S5B). It remains unclear whether this result reflectssamer-c-myc mice with intravitreal injection of AAV-PLAP (n = 5) or AAV-Cre
ces distal from the lesion. ***p < 0.001, **p < 0.01, and *p < 0.05, t test. Error bars
ole-mount retinas from intact Rosamer-c-mycmice (n = 5) or injured Rosamer-
, ANOVA with Bonferroni post test. Error bars indicate SEM.
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Figure 4. Delayed c-myc Expression Promotes RGC Survival and Axon Regeneration after Optic Nerve Injury
(A) Timeline for delayed activation of c-myc after the optic nerve injury.
(B) Representative confocal images of CTB-labeled optic nerve sections from control (AAV2-PLAP, n = 5) and Rosamer-c-myc (c-Myc) mice (n = 7). Scale bar,
100 mm.
(C) Quantification of regenerative axons counted at different distances distal from the lesion. t test. ***p < 0.001 and *p < 0.05. Error bars indicate SEM.
(D) Representative images of whole-mount retinas, stained with anti-Tuj1, from intact, injured control (AAV2-PLAP, n = 5), and injured c-myc mice (AAV2-Cre,
n = 7). Scale bar, 20 mm. Error bars indicate SEM.
(E) Quantification of Tuj1+ RGCs in different groups. AI, after injury; BI, before injury. ANOVA with Bonferroni post test. ***p < 0.001. Error bars indicate SEM.
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the differential involvement of c-myc in RGC subtypes or the
compensatory effects of other myc members.
Synergistic Effects of c-myc Overexpression and PTEN
and SOCS3 Deletion
Our systems biology analyses of the pathways involved in the
neuronal response to injury strongly suggest that other major
signaling hubs work in concert with c-myc (Figures 2B and
2C). To better understand their functional interactions, we
analyzed the combinatorial effects in the optic nerve injury model
by manipulating both c-myc and the mTOR pathway, which was
also implicated by the network analysis (Figure 2). Thus, we per-
formed an intravitreal co-injection of AAV2-Cre, together with
AAV2-c-myc or AAV2-PLAP, in PTENf/f mice (Figure 5A). At
2 weeks after injury, we observed significant increase in neuronal
survival and axon regeneration in the PTENf/f mice with c-myc
expression with around 75% of RGCs alive (Figures 5B–5D).
As our previous studies showed robust axon regeneration af-
ter co-deletion of PTEN and SOCS3 in RGCs (Sun et al., 2011),
we further examined the effects of this co-deletion in combina-
tion with c-myc overexpression (Figure 6A). Thus we performed
an intravitreal co-injection of AAV2-Cre and AAV2-CNTF,
together with AAV2-c-myc or AAV2-PLAP, in PTENf/f/SOCS3f/f
mice. As shown in Figure 6B, such a combinatorial treatment
resulted in further-enhanced axon regeneration. At 4 weeks
post-injury, about 5 times more regenerating axons reached
the proximal end of the chiasm when compared with PTEN/
SOCS3 deletion alone (Figures 6B, 6C, and S6). In the mice
with PTEN/SOCS3 co-deletion, the majority of regenerating
axons ceased growing in the proximal end of the chiasm (Luo
et al., 2013; Sun et al., 2011). However, with additional c-myc
expression, while some axons grew ectopically into the contra-
lateral optic nerve, many more axons crossed the chiasm and
continued to grow in the optic tracts, with some ipsilaterally,
and more contralaterally (Figures 6B and 6E). After crossing
the chiasm, many regenerating axons derail from the optic tract,
similar to the results shown by Luo et al., 2013. At 8 weeks post-
injury, while most of regenerating axons disappeared in the mice
with PTEN/SOCS3 deletion without c-myc expression, many re-
generating axons remained in the mice with triple treatment (Fig-
ure S7). In these animals, however, the numbers of regenerating
axons are reduced to some extent (Figure S7), possibly due to
the elimination of regenerating axons that have not formed
proper synaptic connections. These results suggested that co-
manipulation of these injury-response pathways could result in
a synergistic effect on promoting neuronal survival and axon
regeneration.
Differential Injury Responses in RGCs and DRG Neurons
As the neurons in the PNS and theCNS differ in their regenerative
ability, we examined how these injury-regulatory pathways are
differentially regulated in regeneration-competent DRG neurons.
As shown in Figure 7, the c-myc expression level, measured by
qPCR with the mRNA samples from DRGs, was significantly
increased at 1 day post-injury, but returned to the basal levels
from 3 days post-injury. Consistent with the regulation of c-
myc transcripts, the protein abundance of c-myc as measured
using anti-c-myc antibodies showed delayed increase at3 days post-injury (Figure 7B). In addition, we also monitored
the mTOR activation levels by immunohistochemistry with anti-
phospho-S6 antibodies. As shown in Figure 7C, the phospho-
S6 is significantly increased in DRG neurons with a sciatic nerve
injury, in contrast to the injury-induced mTOR downregulation
observed in RGCs (Figures 2 and S6; Park et al., 2008). These re-
sults revealed a correlation between the activation levels of these
pathways and the neuronal regenerative ability, suggesting the
critical roles of these and other identified injury-responsive mol-
ecules in determining the intrinsic regenerative ability in mature
neurons.DISCUSSION
By using a systems biology analysis of protein abundance
changes measured by quantitative mass spectrometry followed
by bioinformatics analyses, we identified a network of molecular
pathways that are altered in injured RGCs. Manipulations of two
of these pathways, myc and mTOR, resulted in dramatically
increased neuronal survival and axon regeneration. Although
the combined effects with other pathways remain to be tested,
these results suggest the possibility that manipulation of these
injury-response pathways simultaneously might represent a
powerful strategy for promoting neuronal survival and axon
regeneration.
While it has been proposed that the intrinsic regenerative abil-
ity is a critical determinant of axon regeneration, its molecular
signatures and its regulatory mechanisms remain poorly under-
stood. Our results provide mechanistic evidence for the hypoth-
esis that injury-triggered stress responses might be important to
the loss of intrinsic regenerative ability observed in the adult
RGCs. The major injury-altered signaling pathways identified in
this study could be strong potential molecular determinants,
which might play different roles in regulating the intrinsic capac-
ity to regenerate upon injury. For example, the components of
the MAPK pathway were found on the list of the identified
injury-response pathways, consistent with ample evidence sup-
porting MAPK activation as an evolutionarily conserved injury
signal (Chen et al., 2011; Hammarlund et al., 2009; Watkins
et al., 2013). Similarly, the current studies point to a critical role
for injury-triggered responses in downregulating the mTOR ac-
tivity, an implicated player in regulating neuronal survival and
axon regeneration after injury (Liu et al., 2010; Park et al.,
2008; Sun et al., 2011). In addition, our analysis also reveals a
number of novel putative injury-response molecules, such as
c-myc, NFkb, and HTT, which might provide new avenues of
exploration to understand the molecular mechanisms of intrinsic
regenerative ability. Our further analysis on c-myc provides
compelling evidence verifying the role of such novel molecular
players in neuronal injury responses. Forced expression of c-
myc in RGCs, either before or after injury, promotes neuronal
survival and axon regeneration, and this effect is further ampli-
fied by the combined deletion of PTEN and SOCS3. Importantly,
both c-myc and mTOR are differentially regulated in regenera-
tion-competent peripheral sensory neurons, suggesting a possi-
bility that the role of these molecules in affecting the intrinsic
regenerative ability might not be limited to a single neuronal type.Neuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc. 1007
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Figure 5. Synergistic Effect of PTEN Deletion with c-myc Overexpression
(A) Timeline of experimental procedures.
(B) Representative confocal images of the optic nerve sections from PTENf/f (infected with AAV2-Cre), Rosamer-myc (infected with AAV2-Cre and treated with
tamoxifen), and PTENf/f mice infected with AAV2-Cre and AAV2-c-myc. Axons are labeled with CTB. Red stars indicate the crush site. Scale bar, 100 mm.
(C) Quantification of regenerative axons in the three groups presented in (B). ANOVA with Bonferroni post test. *p < 0.05. Error bars indicate SEM.
(D) Quantification of RGC survival as measured by Tuj1 staining ANOVA with Bonferroni post test. ***p < 0.001 and *p < 0.05. Error bars indicate SEM.How c-myc acts in injury responses remains unclear. c-myc is
described as being a master transcription factor that regulates
genes involved in different aspects of anabolic metabolism,
such as ribosome biogenesis, lipid synthesis, nucleic acid syn-1008 Neuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc.thesis, intermediary metabolism, and cell growth and prolifera-
tion (Dang, 2013). Our data suggest that the activity of c-myc
is a key step toward achieving successful axon regeneration af-
ter an injury to override a shift in metabolic state that usually
AB
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Figure 6. c-myc Expression Enhances Optic Nerve Regeneration Induced by Co-deletion of PTEN and SOCS3 in RGCs
(A) Timeline of the experimental procedures.
(B) Representative confocal images of CTB-labeled optic nerve whole-mounts from PTENf/f/SOCS3f/f mice with intravitreal injection of AAV2-Cre, AAV2-CNTF,
and AAV2-c-myc (n = 6) or AAV2-Cre, AAV2-CNTF, and AAV2-PLAP (n = 6). Optic nerve crush was performed on the right optic nerve head, and regenerative
axons were labeled with CTB. Red stars indicate the crush site. Scale bar, 100 mm.
(C and D) Quantification of the numbers of regenerating axons at the proximal end of the chiasm (C) and regenerating axons that passed the chiasm, including
those crossing the midline (contra) and navigating ipsilaterally (ipsi) (D). Error bars indicate SEM.
(E) Distribution of regenerating axons projecting in the contralateral optic nerve (gray), the contralateral optic tract (white), and ipsilateral optic tract (black) in the
groups of PS (PTENf/f/SOCS3f/f with AAV2-Cre, AAV2-CNTF, and AAV2-PLAP) and PSM (PTENf/f/SOCS3f/f with AAV2-Cre, AAV2-CNTF, and AAV2-c-myc). t test,
***p < 0.001 and *p < 0.05. Error bars indicate SEM.
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Figure 7. c-myc Expression andmTORActiva-
tion in Injured DRG Neurons
(A) The quantification of the c-myc mRNA levels
measured by qPCR on the mRNA extracted from
intact L4–6 DRGs or at different time points after
sciatic nerve crush. Results are normalized against
GAPDH, and the levels of c-myc expression in intact
DRGs were used as references. One day after injury
there is an increase in c-myc RNA. ANOVA test, ***p <
0.001. Error bars indicate SEM.
(B) DRG sections collected before sciatic nerve crush
(no injury) or 1, 3, or 7 days post-crush (DPC). DRG
sections are stained with c-myc (green), NeuN (red),
and DAPI (blue). c-myc expression increases after
sciatic nerve injury. Scale bar, 50 mm.
(C) DRG sections from different conditions are
stained with Tuj1 (red), anti-phospho-S6 (green), and
DAPI (blue). The phospho-S6 immunoreactivity in-
creases after sciatic nerve injury. Scale bar, 50 mm.
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results in the degeneration of axons and eventual apoptosis. This
is especially important for the mature neurons in the adult,
because in these resting cells the ATP is mainly generated by
catabolic processes and is used to maintain energy-costly ho-
meostatic processes, such as cytoskeletal functions and ion
and nutrient transport. However, for an injured neuron to initiate
regenerative growth, it has to shift toward anabolic processes,
allowing for the de novo synthesis of macromolecules from avail-
able nutrients. In fact, mTOR has also been implicated as an
important regulator of cell metabolism, because it can alter
cellular metabolism to drive the biosynthesis of building blocks
andmacromolecules essential for cell growth (Guertin and Saba-
tini, 2007; Xie and Proud, 2013). Therefore, a plausible model is
that c-myc alone or together with mTORmight allow injured neu-
rons to achieve such a shift of metabolic states for axonal re-
growth. It would also be interesting to test whether other meta-
bolic modulating methods could alter neuronal regenerative
ability. On the other hand, recent studies documented an in-
crease in c-myc protein in the promoter region of active genes
as opposed to regulating the expression of specific genes,
thus amplifying the overall output of the existing gene expression
program in tumor cells (Lin et al., 2012; Nie et al., 2012). Thus, an
alternative model is that c-myc might act similarly in neurons by
boosting the general gene expression, whichmay explain its dra-
matic effect on increasing the regeneration observed in combi-
nationwith thePTEN/SOCS3 deletion. Understanding how these
and other pathways act in neuronal injury responses holds prom-
ise in identifying new targets for designing new strategies to pro-
mote neuronal survival and axon regeneration.
The identification of injury-response networks by systems-
wide approaches as used in this study may also provide an
example for investigating the pathogenesis of other types of
neurological diseases, because how different types of neurons
respond to specific stress conditions remains an unsolved
mystery. For example, the abnormal expression of pathological
proteins, such as amyloid-b or mutant superoxide dismutase 1
(SOD1), might be critical for the development of Alzheimer’s dis-
ease or amyotrophic lateral sclerosis. In these cases, despite the
ubiquitous expression of pathological proteins in all cell types,
often only subtypes of neurons exhibit pathological alterations
and neuronal loss, suggesting that similar to injury responses,
neurons may differ in their responses to other types of stress
conditions. It therefore will be valuable to analyze the stress-
response programs in individual neuronal types and to test
whether similar or different stress-response programs are acti-
vated in other pathological conditions, and manipulating such
pathways could be beneficial.EXPERIMENTAL PROCEDURES
Surgical Procedures
All experimental procedures were performed in compliance with animal pro-
tocols approved by the IACUC at Boston Children’s Hospital. For all surgical
procedures, mice were anesthetized with ketamine and xylazine. Eye oint-
ment containing atropine sulfate was applied to protect the cornea during
surgery. Animals received buprenorphine for 24 hr as a post-operative
analgesic.Mouse Lines
C57BL6/J mice are used as wild-type controls. PTENf/f mice are main-
tained in BALB/cAnNTac genetic background (JAX). SOCS3f/f mice are in
C56/129 background (JAX). Mycf/f mice are in C57BL6/J background
(JAX). Myc Rosamer mice (Ja¨ger et al., 2004) are maintained in 129/SV back-
ground. We crossed the PTENf/f and Socs3f/f lines obtained from JAX to
generate the PTENf/f/Socs3f/f double mutants. The background of this mouse
line is mixed. This mouse line has been previously described (Sun et al.,
2011).
AAV2 Virus Injection
C57BL6/J mice (used as wild-type controls), PTENf/f mice, and Rosamer-myc
mice were injected intravitreally (to their right eyes) with 1.5 ml of AAV2-Cre,
AAV2-myc, AAV2-CNTF, AAV2-ShPTEN, or AAV2-PLAP (titers around 1 3
1012). PTENf/f/SOCS3f/f mice (Sun et al., 2011) were injected first with AAV2-
Cre and AAV2-CNTF and then AAV2-PLAP or AAV2-c-myc. For each injection,
a glass micropipette was inserted to peripheral retina, behind ora serrate to
avoid damage to the lens.
Optic Nerve Injury
At 2weeks or 4 weeks for AAV2-ShPTEN following the AAV2 injection, the right
optic nerve was exposed intraorbitally and crushed with forceps (Dumont #5,
Fine Science Tools) for 5 s approximately 1 mm behind the eye ball, as previ-
ously described (Park et al., 2008; Sun et al., 2011).
RGC Anterograde Labeling
At 3 days before termination, 1.5 ml of CTB conjugated to Alexa 488 (2 mg/ml,
Invitrogen) was injected into the vitreous chamber with syringe (Hamilton) to
label axons in optic nerve. All tissues were processed as described previously
(Park et al., 2008; Sun et al., 2011).
Sciatic Nerve Crush
The right sciatic nerve was exposed and crushed with forceps (Dumont #5,
Fine Science Tools) for approximately 20 s.Axon Regeneration Quantification
Number of regenerating axons in the optic nerve was estimated by counting
the number of CTB-labeled axons at different distances from the crush site
as described previously (Park et al., 2008; Sun et al., 2011).Immunohistochemistry
Sections or whole-mount retinas were incubated overnight at 4C with
primary antibodies: Tuj1 (1/400, Covance), P-S6 (1/200, Cell Signaling Tech-
nology), NeuN (1/100, Millipore), and c-myc (1/200, Abcam) diluted in PBS,
BSA (3%) Triton X-100 (0.5%) as described in Nawabi et al. (2010). Then,
tissues were incubated for 2 hr at room temperature with appropriate Alexa
Fluor conjugate secondary antibodies (Alexa 488, Alexa 594, Alexa 674; Invi-
trogen) diluted with the same blocking solution as the primary antibodies.
Sections or whole-mount retinas were mounted with DAPI-Fluoromont-G
(Solulink).RGCs Survival and Phospho-S6 Signal
Tuj1-positive cells in the ganglion layer were counted using a fluorescent mi-
croscope after immunostaining whole-mount retinas with anti-Tuj1 antibodies.
A total of eight random fields per retina were enumerated. The average number
per field was determined, and the percentages of viable RGCs were obtained
by comparing the values determined from the uninjured contralateral retinas.
In the same condition, after phospho-S6 staining, the densities of phopsho-
S6-positive RGCs were obtained by comparing the value from the uninjured
contralateral retinas.Whole-Mount Optic Nerve Preparation
Optic nerves were prepared as described in Dodt et al. (2007). Briefly, optic
nerves were post-fixed overnight at 4C in PFA 4%, then dehydrated in ethanol
(50%, 80%, and 95% for 20 min each). Optic nerves were incubated for 1 hr in
ethanol 100% and then 2 hr in hexane (Sigma). Finally, samples were trans-
ferred in benzyl benzoate/benzyl alcohol (2:1 in volume; Sigma) clearing
solution.Neuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc. 1011
Imaging
Optic nerves from different experiments (sections and whole mount) were
imaged using a spinning disk confocal microscope (Zeiss) with Velocity soft-
ware (PerkinElmer). A 203 objective was used to acquire image stacks with
a 2-mm z spacing and 20% overlap in the (x;y) dimensions. The motorized
stage enables the automation of the imaging procedure. All the images were
then stitched together using the Velocity software and z-projected to maximal
intensity for quantification. Whole-mount retinas were imaged with a Nikon 80i
epifluorescence microscope with 203 objective. At least eight random fields
were imaged per retina.Statistical Analysis
One-way ANOVAs were performed using PRISM software, and specific differ-
ences between groups were confirmed with Bonferroni t test. When two
groups were compared, t test was used.FACS Analysis
YFP-17 mice were subjected to optic nerve injury. At 3 days after injury, ani-
mals were euthanized, and injured or intact retinas were immediately
dissected out for dissociation. Retinas were collected in 800 ml HBSS supple-
mented with trypsin (5 mg/ml) and DNase (0.2 mg/ml) for 10 min at 37C.
Retinas were washed three times with DMEM/10% FBS and dissociated me-
chanically using a P1000 pipetman. Cells were pelleted by centrifugation for
5 min at 200 3 g suspended in Neurobasal supplemented with L-glutamine
and B27 plus DAPI (1 mg/ml) and filtered through a 40-mmcell strainer (BD Fal-
con) before FACS sorting. FACS sorting was performedwith a BDFACSAria IIu
instrument. Prior to each sorting event, a purity test was performed to ensure
that the specificity for the YFP signal was higher than 99%. Dissociated retinal
cells were separated based on size (forward scatter) and surface characteris-
tics (side scatter) as well as viability (DAPI staining). Aggregated cells were
excluded based on the FSC-H-versus-FSC-A ratio. Retinal cells without YFP
expression were used as negative controls to optimize the detection gate prior
to each sorting. Sorted cells were immediately subjected to either proteins or
RNA extraction.Quantitative Proteomics Analysis of RGC
Cells from each preparation were immediately lysed using Qproteome
mammalian buffer, and proteins were precipitated using chloroform/methanol.
Protein (100 mg) from each sample was reduced with tris(2-carboxyethyl)
phosphine (TCEP) and alkylated with a 0.05 M iodoacetamide solution in the
dark at room temperature (23C) for 20min. A proteolytic digestion was carried
out with trypsin at 37C for 16 hr. Labeling reagents from the TMT 6-plex
Isobaric Label Reagent Set (PI-90064, Thermo Fisher Scientific) were added
to the peptide samples and incubated at room temperature for 1 hr. The reac-
tion was quenched by adding 8 ml of 5% hydroxylamine to the samples, incu-
bated at room temperature for 1 hr and combined together. Peptides were
eluted from the spin columns. After acidification, the peptides were desalted
on anOASISHLB column (Waters) and evaporated to dryness, prior to isoelec-
tric focusing fractionation according to their isoelectric point. Resultant
peptide fractions were dried before re-suspension in MS loading buffer (5%
acetonitrile, 0.1% formic acid in H2O).
Less than 10 mg of each fraction was analyzed by nano-LC-MS/MS using a
60-min gradient. PQD on the LTQ Orbitrap Classic was used to fragment the
peptide precursor ions. Thermo RAW files were processed using an in-house
informatics pipeline (Bigbang/Horizon) and searched with a MASCOT
(version 2.1) search engine against the IPI mouse protein database (IPI
3.68) using a target-decoy database to calculate the FDR. TMT 6-plex mod-
ifications were set as dynamic modifications in the database search and as
static modifications for all other data analysis. This allowed us to calculate
labeling efficiencies—the labeling efficiency for our experiments was
98.73%. All PSMs used in this analysis had a MASCOT score above 32
and q value below 0.01. Only proteins identified with a high rate of confi-
dence (1% FDR) were used for analysis. Functional analysis was performed
using IPA (Ingenuity Systems). The extended methods are described in Sup-
plemental Information.1012 Neuron 86, 1000–1014, May 20, 2015 ª2015 Elsevier Inc.RNA Extraction
Cells were immediately lysed using a TRIzol reagent (Invitrogen), and RNAwas
purified using the RNeasy RNA extraction kit (QIAGEN). Total RNA (50–100 ng)
was reverse-transcribed and amplified with real-time PCR assays using iQ
SYBR Green (Bio-Rad). Real-time PCR was performed on a Bio-Rad CFX
96. Each sample was run four times in each assay. GADPH was used as the
endogenous control.
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